| 1 | Generalized epilepsy with febrile seizures plus | Enrichment | FGF13, HCN1, SCN1A, SCN1B, SCN2A | 10.08 |
| 2 | Developmental and epileptic encephalopathy | Enrichment | HCN1, SCN1A, SCN2A, SCN3A, SCN8A, STXBP1 | 9.89 |
| 3 | Epilepsy | Enrichment | CHD2, PCDH19, SCN1A, SCN2A, SCN3A, SCN8A | 9.59 |
| 4 | Undetermined early-onset epileptic encephalopathy | Enrichment | HCN1, KCNA2, SCN1A, SCN1B, SCN3A, SCN8A | 8.68 |
| 5 | Dravet syndrome | Enrichment | PCDH19, SCN1A, SCN1B, SCN2A | 8.39 |
| 6 | Benign epilepsy with centrotemporal spikes | Enrichment | CHD2, PCDH19, SCN1A, SCN1B, SCN2A | 7.58 |
| 7 | Centralopathic epilepsy | Enrichment | CHD2, PCDH19, SCN1A, SCN1B, SCN2A | 7.47 |
| 8 | West syndrome | Enrichment | KCNA2, SCN1A, SCN2A, SCN8A, STXBP1 | 7.42 |
| 9 | Familial atrial fibrillation | Enrichment | SCN1B, SCN2B, SCN3B, SCN4B | 6.70 |
| 10 | Long qt syndrome 1 | Enrichment | CALM1, CALM2, CALM3, SCN4B | 6.29 |
| 11 | Catecholaminergic polymorphic ventricular tachycardia | Enrichment | CALM1, CALM2, CALM3 | 6.27 |
| 12 | Generalized epilepsy with febrile seizures plus, type 1 | Enrichment | SCN1A, SCN1B | 4.85 |
| 13 | Autism | Enrichment | SCN1A, SCN2A, SCN8A, STXBP1 | 4.74 |
| 14 | Developmental and epileptic encephalopathy 1 | Enrichment | KCNA2, SCN1A, SCN8A | 4.66 |
| 15 | Brugada syndrome | Enrichment | SCN1B, SCN2B, SCN3B | 4.61 |
| 16 | Hemimegalencephaly | Enrichment | MTOR, PIK3CA | 4.33 |
| 17 | Self-limited infantile epilepsy | Enrichment | SCN2A, SCN8A | 4.33 |
| 18 | Breast adenocarcinoma | Enrichment | AKT1, PIK3CA | 4.15 |
| 19 | Focal epilepsy | Enrichment | SCN2A, SCN8A | 4.01 |
| 20 | Lennox-gastaut syndrome | Enrichment | CHD2, SCN1A | 3.88 |
| 21 | Complex neurodevelopmental disorder | Enrichment | CHD2, KCNA2, SCN2A, SCN8A | 3.82 |
| 22 | Myoclonic-atonic epilepsy | Enrichment | CHD2, SCN1A | 3.77 |
| 23 | Developmental and epileptic encephalopathy 14 | Enrichment | SCN1A, SCN2A | 3.77 |
| 24 | Cowden syndrome | Enrichment | AKT1, PIK3CA | 3.77 |
| 25 | Meningioma | Enrichment | AKT1, PIK3CA | 3.51 |
| 26 | Sudden infant death syndrome | Enrichment | CALM2, SCN1A | 3.20 |
| 27 | Early infantile developmental and epileptic encephalopathy | Enrichment | SCN1B, SCN2A | 3.15 |
| 28 | Malaria | Enrichment | SCN8A, TNF | 2.93 |
| 29 | Strabismus | Enrichment | PCDH19, STXBP1 | 2.79 |
| 30 | Autism spectrum disorder | Enrichment | CHD2, SCN2A, STXBP1 | 2.76 |
| 31 | Long qt syndrome | Enrichment | CALM1, CALM2 | 2.68 |
| 32 | Macrodactyly | Enrichment | PIK3CA | 2.66 |
| 33 | Proteus syndrome | Enrichment | AKT1 | 2.66 |
| 34 | Brugada syndrome 5 | Enrichment | SCN1B | 2.66 |
| 35 | Megalencephaly, autosomal dominant | Enrichment | PIK3CA | 2.66 |
| 36 | Long qt syndrome 10 | Enrichment | SCN4B | 2.66 |
| 37 | Cowden syndrome 5 | Enrichment | PIK3CA | 2.66 |
| 38 | Developmental and epileptic encephalopathy 11 | Enrichment | SCN2A | 2.66 |
| 39 | Atrial fibrillation, familial, 14 | Enrichment | SCN2B | 2.66 |
| 40 | Cerebral cavernous malformations 4 | Enrichment | PIK3CA | 2.66 |
| 41 | Intellectual developmental disorder, x-linked 110 | Enrichment | FGF13 | 2.66 |
| 42 | Intellectual developmental disorder, autosomal recessive 63 | Enrichment | CAMK2A | 2.66 |
| 43 | Myoclonus, familial, 2 | Enrichment | SCN8A | 2.66 |
| 44 | Developmental and epileptic encephalopathy 62 | Enrichment | SCN3A | 2.66 |
| 45 | Developmental and epileptic encephalopathy 90 | Enrichment | FGF13 | 2.66 |
| 46 | Atrial fibrillation, familial, 13 | Enrichment | SCN1B | 2.66 |
| 47 | Hemifacial myohyperplasia | Enrichment | PIK3CA | 2.66 |
| 48 | Developmental and epileptic encephalopathy 32 | Enrichment | KCNA2 | 2.66 |
| 49 | Capillary malformation of the lower lip, lymphatic malformation of face and neck, asymmetry of face and limbs, and partial/generalized overgrowth | Enrichment | PIK3CA | 2.66 |
| 50 | Episodic ataxia, type 9 | Enrichment | SCN2A | 2.66 |
| 51 | Long qt syndrome 16 | Enrichment | CALM3 | 2.66 |
| 52 | Cowden syndrome 6 | Enrichment | AKT1 | 2.66 |
| 53 | Developmental and epileptic encephalopathy 24 | Enrichment | HCN1 | 2.66 |
| 54 | Benign familial infantile epilepsy | Enrichment | SCN2A | 2.66 |
| 55 | Brugada syndrome 7 | Enrichment | SCN3B | 2.66 |
| 56 | Epilepsy, familial focal, with variable foci 4 | Enrichment | SCN3A | 2.66 |
| 57 | Generalized epilepsy with febrile seizures plus, type 10 | Enrichment | HCN1 | 2.66 |
| 58 | Intellectual developmental disorder, autosomal dominant 53 | Enrichment | CAMK2A | 2.66 |
| 59 | Segmental progressive overgrowth syndrome with fibroadipose hyperplasia | Enrichment | PIK3CA | 2.66 |
| 60 | Long qt syndrome 15 | Enrichment | CALM2 | 2.66 |
| 61 | Hypospadias | Enrichment | PIK3CA | 2.66 |
| 62 | Rare venous malformation | Enrichment | PIK3CA | 2.66 |
| 63 | Diaphragmatic eventration | Enrichment | PIK3CA | 2.66 |
| 64 | Pik3ca-related overgrowth spectrum | Enrichment | PIK3CA | 2.66 |
| 65 | Rare combined vascular malformation | Enrichment | PIK3CA | 2.66 |
| 66 | Cavernous lymphangioma | Enrichment | PIK3CA | 2.66 |
| 67 | Pik3ca-related overgrowth syndrome | Enrichment | PIK3CA | 2.66 |
| 68 | Hemihyperplasia-multiple lipomatosis syndrome | Enrichment | PIK3CA | 2.66 |
| 69 | Eccrine angiomatous hamartoma | Enrichment | PIK3CA | 2.66 |
| 70 | Macrodactyly of toe | Enrichment | PIK3CA | 2.66 |
| 71 | Hereditary breast carcinoma | Enrichment | AKT1, PIK3CA | 2.37 |
| 72 | Developmental and epileptic encephalopathy 9 | Enrichment | PCDH19 | 2.35 |
| 73 | Seizures, benign familial infantile, 3 | Enrichment | SCN2A | 2.35 |
| 74 | Ventricular tachycardia, catecholaminergic polymorphic, 4 | Enrichment | CALM1 | 2.35 |
| 75 | Keratosis, seborrheic | Enrichment | PIK3CA | 2.35 |
| 76 | Sifrim-hitz-weiss syndrome | Enrichment | CHD2 | 2.35 |
| 77 | Noonan syndrome 8 | Enrichment | PIK3CA | 2.35 |
| 78 | Immunodeficiency, common variable, 12, with autoimmunity | Enrichment | NFKB1 | 2.35 |
| 79 | Migraine, familial hemiplegic, 3 | Enrichment | SCN1A | 2.35 |
| 80 | Cognitive impairment with or without cerebellar ataxia | Enrichment | SCN8A | 2.35 |
| 81 | Long qt syndrome 14 | Enrichment | CALM1 | 2.35 |
| 82 | Developmental and epileptic encephalopathy 6b | Enrichment | SCN1A | 2.35 |
| 83 | Cebalid syndrome | Enrichment | MTOR | 2.35 |
| 84 | Immunodeficiency 127 | Enrichment | TNF | 2.35 |
| 85 | Rosette-forming glioneuronal tumor | Enrichment | PIK3CA | 2.35 |
| 86 | Benign familial neonatal epilepsy | Enrichment | SCN2A | 2.35 |
| 87 | Developmental and epileptic encephalopathy 30 | Enrichment | SCN2A | 2.35 |
| 88 | Scn1a seizure disorders | Enrichment | SCN1A | 2.35 |
| 89 | Smith-kingsmore syndrome | Enrichment | MTOR | 2.35 |
| 90 | Seizures, benign familial infantile, 5 | Enrichment | SCN8A | 2.35 |
| 91 | 9q33.3q34.11 microdeletion syndrome | Enrichment | STXBP1 | 2.35 |
| 92 | Malignant migrating partial seizures of infancy | Enrichment | SCN2A | 2.35 |
| 93 | Developmental and epileptic encephalopathy 76 | Enrichment | SCN1A | 2.35 |
| 94 | Benign neonatal seizures | Enrichment | SCN2A | 2.35 |
| 95 | Common variable immunodeficiency 12 | Enrichment | NFKB1 | 2.35 |
| 96 | Autosomal dominant non-syndromic intellectual disability | Enrichment | CAMK2A, SCN8A | 2.27 |
| 97 | Spastic ataxia | Enrichment | SCN2A, STXBP1 | 2.22 |
| 98 | Dystonia 12 | Enrichment | SCN2A | 2.18 |
| 99 | Pompe disease, infantile-onset | Enrichment | PIK3CA | 2.18 |
| 100 | Psoriatic arthritis | Enrichment | TNF | 2.18 |
| 101 | Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi | Enrichment | PIK3CA | 2.18 |
| 102 | Generalized epilepsy with febrile seizures plus, type 2 | Enrichment | SCN1A | 2.18 |
| 103 | Developmental and epileptic encephalopathy 13 | Enrichment | SCN8A | 2.18 |
| 104 | Migraine without aura | Enrichment | TNF | 2.18 |
| 105 | Developmental and epileptic encephalopathy 94 | Enrichment | CHD2 | 2.18 |
| 106 | Keratoacanthoma | Enrichment | PIK3CA | 2.18 |
| 107 | Hereditary episodic ataxia | Enrichment | SCN2A | 2.18 |
| 108 | Megalencephaly-capillary malformation-polymicrogyria syndrome | Enrichment | PIK3CA | 2.05 |
| 109 | Developmental and epileptic encephalopathy 4 | Enrichment | STXBP1 | 2.05 |
| 110 | Focal cortical dysplasia, type ii | Enrichment | MTOR | 2.05 |
| 111 | Developmental and epileptic encephalopathy 12 | Enrichment | SCN2A | 2.05 |
| 112 | Developmental and epileptic encephalopathy 52 | Enrichment | SCN1B | 2.05 |
| 113 | Color blindness | Enrichment | HCN1 | 2.05 |
| 114 | Cerebrovascular disease | Enrichment | PIK3CA | 2.05 |
| 115 | Episodic ataxia | Enrichment | SCN2A | 2.05 |
| 116 | Familial cerebral cavernous malformations | Enrichment | PIK3CA | 2.05 |
| 117 | Hereditary progressive cardiac conduction defect | Enrichment | SCN1B | 2.05 |
| 118 | Familial or sporadic hemiplegic migraine | Enrichment | SCN1A | 2.05 |
| 119 | Cerebral malaria | Enrichment | TNF | 2.05 |
| 120 | Isolated focal cortical dysplasia type ii | Enrichment | MTOR | 2.05 |
| 121 | Capillary malformations, congenital | Enrichment | PIK3CA | 1.96 |
| 122 | Convulsions, familial infantile, with paroxysmal choreoathetosis | Enrichment | SCN8A | 1.96 |
| 123 | Vascular dementia | Enrichment | TNF | 1.96 |
| 124 | Breast cancer | Enrichment | AKT1, PIK3CA | 1.93 |
| 125 | Klippel-trenaunay-weber syndrome | Enrichment | PIK3CA | 1.88 |
| 126 | Cowden syndrome 1 | Enrichment | PIK3CA | 1.88 |
| 127 | Hemihyperplasia, isolated | Enrichment | PIK3CA | 1.88 |
| 128 | Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy | Enrichment | CALM1 | 1.88 |
| 129 | Lung squamous cell carcinoma | Enrichment | PIK3CA | 1.88 |
| 130 | Glycine encephalopathy | Enrichment | PCDH19 | 1.88 |
| 131 | Nevus, epidermal | Enrichment | PIK3CA | 1.81 |
| 132 | Polymicrogyria, bilateral perisylvian, x-linked | Enrichment | SCN3A | 1.81 |
| 133 | Capillary malformation-arteriovenous malformation 1 | Enrichment | PIK3CA | 1.81 |
| 134 | Renal cell carcinoma, papillary, 1 | Enrichment | MTOR | 1.81 |
| 135 | Gallbladder cancer | Enrichment | PIK3CA | 1.81 |
| 136 | Common variable immunodeficiency | Enrichment | NFKB1 | 1.81 |
| 137 | Overgrowth syndrome | Enrichment | MTOR | 1.81 |
| 138 | Colorectal cancer | Enrichment | AKT1, PIK3CA | 1.80 |
| 139 | Glycine encephalopathy 1 | Enrichment | PCDH19 | 1.76 |
| 140 | Alternating hemiplegia of childhood | Enrichment | SCN2A | 1.76 |
| 141 | Catecholaminergic polymorphic ventricular tachycardia 1 | Enrichment | CALM1 | 1.76 |
| 142 | Arteriovenous malformation | Enrichment | PIK3CA | 1.70 |
| 143 | Adult hepatocellular carcinoma | Enrichment | PIK3CA | 1.70 |
| 144 | Bilateral perisylvian polymicrogyria | Enrichment | SCN3A | 1.70 |
| 145 | Ovarian cancer | Enrichment | AKT1, PIK3CA | 1.68 |
| 146 | Myopathy, x-linked, with excessive autophagy | Enrichment | PIK3CA | 1.66 |
| 147 | Ciliary dyskinesia, primary, 3 | Enrichment | NFKB1 | 1.66 |
| 148 | Polymicrogyria | Enrichment | SCN3A | 1.66 |
| 149 | Asthma | Enrichment | TNF | 1.62 |
| 150 | Lung non-small cell carcinoma | Enrichment | PIK3CA | 1.62 |
| 151 | Movement disease | Enrichment | SCN2A | 1.62 |
| 152 | Cardiac conduction defect | Enrichment | SCN1B | 1.58 |
| 153 | Lip and oral cavity carcinoma | Enrichment | PIK3CA | 1.58 |
| 154 | Alzheimer's disease | Enrichment | TNF | 1.55 |
| 155 | Microcephaly | Enrichment | SCN1A, STXBP1 | 1.52 |
| 156 | Renal cell carcinoma, nonpapillary | Enrichment | MTOR | 1.49 |
| 157 | Lynch syndrome | Enrichment | PIK3CA | 1.49 |
| 158 | Rare genetic intellectual disability | Enrichment | MTOR | 1.49 |
| 159 | Endometrial cancer | Enrichment | PIK3CA | 1.34 |
| 160 | Hepatocellular carcinoma | Enrichment | PIK3CA | 1.32 |
| 161 | Bladder cancer | Enrichment | PIK3CA | 1.21 |
| 162 | Prostate cancer | Enrichment | PIK3CA | 1.21 |
| 163 | Lung cancer | Enrichment | PIK3CA | 1.16 |
| 164 | Fetal akinesia deformation sequence 1 | Enrichment | SCN8A | 1.10 |
| 165 | Systemic lupus erythematosus | Enrichment | TNF | 1.08 |
| 166 | Distal arthrogryposis | Enrichment | SCN8A | 1.05 |
| 167 | Gastric cancer | Enrichment | PIK3CA | 1.04 |
| 168 | Body mass index quantitative trait locus 11 | Enrichment | SCN1A | 0.98 |
| 169 | Hypertelorism | Enrichment | PIK3CA | 0.96 |
| 170 | Primary ovarian insufficiency | Enrichment | RICTOR | 0.91 |